These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6138285)

  • 1. [Effects of cysteamine on canine splanchnic D-cells].
    Kawai K
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):962-72. PubMed ID: 6138285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of somatostatin deficiency on cell distribution within the Langerhans islets.
    Fujita Y; Amemiya H; Abe Y; Takada I; Ishii K; Yajima Y; Yamamoto N; Miyazawa H; Okabe H
    Diabetes Res Clin Pract; 1985-1986 Mar; 1(6):335-42. PubMed ID: 2873009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function.
    Sorenson RL; Grouse LH; Elde RP
    Diabetes; 1983 Apr; 32(4):377-9. PubMed ID: 6131850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in the depleting effect of cysteamine on pancreatic somatostatin.
    Hashimoto N; Kanatsuka A; Makino H; Sakurada M; Yoshida S
    Horm Metab Res; 1987 Jan; 19(1):11-4. PubMed ID: 2881872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine exerts multiple effects on the endocrine cells of the rat pancreas.
    Ostenson CG; Efendić S
    Biochim Biophys Acta; 1985 Aug; 846(2):242-7. PubMed ID: 2862920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in somatostatin and other islet cell functions in the spontaneously diabetic BB Wistar rat: biochemical and morphological characterization.
    Patel YC; Ruggere D; Malaisse-Lagae F; Orci L
    Metabolism; 1983 Jul; 32(7 Suppl 1):18-25. PubMed ID: 6135136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid depletion of somatostatin in isolated mouse pancreatic islets after treatment with cysteamine.
    Petersson B; Hellerström C
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):227-31. PubMed ID: 2865862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
    Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteamine and the endocrine pancreas: immunocytochemical, immunochemical, and functional aspects.
    Ahrén B; Böttcher G; Ekman R; Sundler F
    Cell Tissue Res; 1989 Apr; 256(1):159-66. PubMed ID: 2653642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone release from pancreatic islets perfused from venous side.
    Kawai K; Chiba Y; Okuda Y; Yamashita K
    Diabetes; 1987 Mar; 36(3):256-60. PubMed ID: 2879756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating somatostatin acts on the islets of Langerhans by way of a somatostatin-poor compartment.
    Kawai K; Ipp E; Orci L; Perrelet A; Unger RH
    Science; 1982 Oct; 218(4571):477-8. PubMed ID: 6126931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo study of glucose-induced somatostatin secretion: comparison in normal and alloxan-diabetic dogs.
    Ribes G; Gross R; Chenon D; Puech R; Loubatieres-Mariani MM
    Pancreas; 1987; 2(6):638-44. PubMed ID: 2894026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new benzothiadiazine derivative, LN 5330: effects on pancreatic hormones.
    Hillaire-Buys D; Ribes G; Blayac JP; Loubatières-Mariani MM
    Diabetologia; 1984 Dec; 27(6):583-6. PubMed ID: 6152237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of somatostatin in regulation of insular-acinar axis.
    Müller MK; von Schönfeld J; Singer MV
    Dig Dis Sci; 1993 Aug; 38(8):1537-42. PubMed ID: 7688275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.